2 IL-31 is a neuroimmune cytokine that drives itch and is involved in inflammation and skin barrier dysfunction in both atopic dermatitis and prurigo nodularis. 11-13 “This positive opinion represents ...
Years of translational research have successfully improved treatment outcomes for common dermatological conditions such as psoriasis and atopic dermatitis through the integration of biologics and ...
Translational research and innovative therapies have opened new frontiers in understanding atopic dermatitis (AD), focusing on key areas such as abnormal immune responses, pruritus, microbial ...